Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.
AJOB Empir Bioeth. 2024 Jul-Sep;15(3):226-235. doi: 10.1080/23294515.2024.2302994. Epub 2024 Jan 9.
There are intense discussions about the ethical and societal implications of biomedical engineering, but little data to suggest how scientists think about the ethics of their work. The aim of this study is to describe how scientists frame the ethics of their research, with a focus on the field of molecular systems engineering.
Semi-structured qualitative interviews were conducted during 2021-2022, as part of a larger study. This analysis includes a broad question about how participants view ethics as related to their work, with follow up probes about the topics they consider most important. Interviews were transcribed, inductively coded by two researchers to consensus, and analyzed thematically.
Twenty-four scientists participated in the study. Interviewees hold positions as professors, principal investigators, and senior staff researchers in universities or research institutes in the United States and Europe. Among those scientists who reported reflecting on ethical considerations in their work, many equated ethics with research ethics topics (e.g., safety, replicability), or with regulation and guidelines. Participants expressed the view that ethical issues are primarily relevant for clinical trials of bioengineered products, or for those working with animal or human subjects. Scientists described their research as "too early" or "not examining anything living" with regard to ethical reflection. Finally, many felt that ethics is seen as territory for experts and therefore beyond scientists' competencies.
Molecular systems engineering scientists currently focus on regulatory aspects as the framework for their ethical analyses. They describe using a framework to define when life arises, as a means to determine when further ethical engagement is warranted. Further research is needed to investigate how scientists relate to the ethics of their scientific work, and build consensus around concepts of life, autonomous behavior, and physiological relevance of bioengineered systems.
关于生物医学工程的伦理和社会影响存在激烈的讨论,但几乎没有数据表明科学家如何思考其工作的伦理问题。本研究的目的是描述科学家如何构建其研究的伦理框架,重点关注分子系统工程领域。
2021 年至 2022 年期间进行了半结构化定性访谈,作为一项更大研究的一部分。本分析包括一个关于参与者如何将伦理视为与他们的工作相关的广泛问题,以及后续关于他们认为最重要的主题的探究。访谈进行了转录,由两位研究人员进行归纳编码以达成共识,并进行了主题分析。
24 位科学家参与了这项研究。受访者在美国和欧洲的大学或研究机构担任教授、首席研究员和高级研究人员。在那些报告在工作中反思伦理考虑的科学家中,许多人将伦理等同于研究伦理主题(例如,安全性、可重复性),或等同于法规和指南。参与者认为伦理问题主要与生物工程产品的临床试验或与动物或人类受试者合作的相关。科学家们认为他们的研究“还为时过早”或“不研究任何活体”,因此无需进行伦理反思。最后,许多人认为伦理是专家的领域,因此超出了科学家的能力范围。
分子系统工程科学家目前将监管方面作为其伦理分析的框架。他们描述了使用框架来定义生命何时出现,作为确定何时需要进一步伦理参与的手段。需要进一步研究以调查科学家如何与他们的科学工作的伦理相关,并就生命、自主行为和生物工程系统的生理相关性等概念达成共识。